Disability in progressive MS is associated with T2 lesion changes
Cecilie Ammitzbøll(University of Copenhagen), Finn Sellebjerg(Danish Multiple Sclerosis Center), Rikke Ratzer(University of Copenhagen), Ellen Garde(University of Copenhagen), Hartwig R. Siebner(Universität Hamburg), Mark Lyksborg(Technical University of Denmark), Per Soelberg Sørensen(University of Copenhagen), Jeppe Romme Christensen(Aarhus University Hospital), Karen Schreiber(Guy's and St Thomas' NHS Foundation Trust), Tim B. Dyrby(Hvidovre Hospital), Pernille Iversen(University of Copenhagen), Melinda Magyari(University of Copenhagen)
Cited by 10
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
Multiple Sclerosis Severity Score
|Neurology|2005|957